Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised
02:10pm, Wednesday, 07'th May 2025
COR's second-quarter fiscal 2025 results showcase a strong segmental performance. The company's earnings guidance for fiscal 2025 looks encouraging.
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings
02:06pm, Wednesday, 07'th May 2025
Cencora, Inc COR on Wednesday reported second-quarter 2025 sales increased 10.3% to $75.5 billion, missing the consensus of $75.68 billion, primarily due to an 11.4% increase in revenue within the U
Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript
10:55am, Wednesday, 07'th May 2025
Cencora, Inc. (NYSE:COR ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Bob Mauch - Preside
Cencora (COR) Beats Q2 Earnings and Revenue Estimates
08:40am, Wednesday, 07'th May 2025
Cencora (COR) came out with quarterly earnings of $4.42 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.80 per share a year ago.
Cencora raises annual profit forecast on strong demand for specialty drugs
07:27am, Wednesday, 07'th May 2025
U.S. drug distributor Cencora raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.
Cencora Reports Fiscal 2025 Second Quarter Results
06:30am, Wednesday, 07'th May 2025
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion.
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
11:15am, Tuesday, 06'th May 2025
The medical device sector saw steady sales growth in the first quarter of 2025, supported by innovation in AI, wearables, and personalized care. However, earnings gains were more modest as global tari
Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
06:00am, Tuesday, 06'th May 2025
VANCOUVER, BC / ACCESS Newswire / May 6, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (WKN: A116E1) ("Camino" or the "Company") is pleased to announce exploration results at its Coppe
Will Speciality and GLP-1 Drugs Help COR Beat Q2 Earnings Estimates?
08:25am, Monday, 05'th May 2025
COR's fiscal second-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
Unveiling Cencora (COR) Q2 Outlook: Wall Street Estimates for Key Metrics
10:20am, Friday, 02'nd May 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cencora (COR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Cencora (COR) Earnings Expected to Grow: Should You Buy?
11:08am, Wednesday, 30'th Apr 2025
Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year?
10:46am, Monday, 21'st Apr 2025
Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Thursday, 17'th Apr 2025
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes
10:55am, Thursday, 17'th Apr 2025
Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
10:50am, Thursday, 17'th Apr 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
